US Patent Issued to Janssen Biotech on Oct. 21 for "Immune targeting molecules and uses thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,449, issued on Oct. 21, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Immune targeting molecules and uses thereof" was invented by Iqbal S. Grewal (Newtown, Pa.), Michael Riis Hansen (Broomall, Pa.), Rajkumar Ganesan (Blue Bell, Pa.) and Sanjaya Singh (Blue Bell, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein, in certain aspects, are antibodies that bind to CD28, as well as recombinant cells containing the vectors, and compositions comprising the antibodies. Also provided herein, in certain aspects, are multispecific antibodies that bind to CD28, as well as recombinant cells containing the vectors, and compositions compri...